Gadopentetate dimeglumine and Lithium Controlled-Release and Extended-Release Tablets
Determining the interaction of Gadopentetate dimeglumine and Lithium Controlled-Release and Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: gadopentetate dimeglumine
Brand name: Magnevist, Multihance
Synonyms: Gadopentetate Injection
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Gadopentetate dimeglumine-Lithium ER
- Gadopentetate dimeglumine-Lithium Oral Solution
- Gadopentetate dimeglumine-Lithium Salts
- Gadopentetate dimeglumine-Lithium Syrup and Oral Solution
- Gadopentetate dimeglumine-Lithobid
- Gadopentetate dimeglumine-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-Gadopentetate Injection
- Lithium Controlled-Release and Extended-Release Tablets-Gadopentetate Intravenous
- Lithium Controlled-Release and Extended-Release Tablets-Gadoterate Intravenous
- Lithium Controlled-Release and Extended-Release Tablets-Gadoterate meglumine
- Lithium Controlled-Release and Extended-Release Tablets-Gadoteridol
- Lithium Controlled-Release and Extended-Release Tablets-Gadoteridol Intravenous